Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study
Samoylenko, Igor V, Kolontareva, Yulia M, Kogay, Ekaterina V, Zhukova, Natalia V, Utyashev, Igor A, Ivannikov, Mikhail E, Menshikov, Konstantin V, Zinkevich, Maxim V, Orlova, Kristina V, Vakhabova, Yulia V, Volkonsky, Mikhail V, Beliaeva, Natalia A, Butkov, Ivan I, Karabina, Elena V, Moskovkina, Tatyana L, Moshkova, Kseniya A, Plishkina, Olga V, Sychev, Vitaliy D, Cheplukhova, Oxana S, Chernova, Vera V, Yurchenkov, Alexandr N, Babina, Ksenia G, Savelov, Nikita A, Demidov, Lev V
Published in Frontiers in oncology (14.10.2024)
Published in Frontiers in oncology (14.10.2024)
Get full text
Journal Article